Blood pressure, insulin secretion and resistance in nonhypertensive and hypertensive obese female subjects. 1995

D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
Istituto di Clinica Medica I, Policlinico Universitario, Paolo Giaccone Piazza delle Cliniche, Palermo, Italy.

OBJECTIVE To study the relationships between blood pressure, insulin secretion and insulin resistance in obese female subjects. METHODS Evaluation of insulin-secretion and resistance respectively by blood C-peptide determination and glucose clamp technique in nonhypertensive and hypertensive obese female subjects. METHODS Outpatient clinic of University Hospital. METHODS 12 female obese subjects, six of whom were nonhypertensive, and six hypertensive; and nine nonobese nonhypertensive subjects as control. METHODS Baseline and during OGTT blood C-peptide as insulin secretion index; M, MCR and M/I ratio evaluated by euglycemic hyperinsulinemic clamp as expression of insulin resistance. RESULTS No difference is shown in C-peptide levels, between the two groups of obese subjects; the M, MCR and M/I values are significantly lower in hypertensive obese vs nonhypertensive obese subjects and controls (P < 0.001). Considering all the subjects, the same parameters are significantly inversely correlated with mean blood pressure values (P < 0.001). CONCLUSIONS In the groups of considered obese subjects, homogeneous for age, sex, body weight excess, fat distribution and glucose tolerance, blood pressure values are directly related to insulin resistance but not to insulin secretion.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001824 Body Constitution The physical characteristics of the body, including the mode of performance of functions, the activity of metabolic processes, the manner and degree of reactions to stimuli, and power of resistance to the attack of pathogenic organisms. Body Constitutions,Constitution, Body,Constitutions, Body
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide

Related Publications

D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
May 1999, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
October 2006, Clinical and experimental hypertension (New York, N.Y. : 1993),
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
June 1991, Hypertension (Dallas, Tex. : 1979),
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
October 1990, Archives of internal medicine,
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
September 1990, International journal of obesity,
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
January 1983, Hypertension (Dallas, Tex. : 1979),
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
June 1999, Internal medicine (Tokyo, Japan),
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
January 2003, Blood pressure,
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
November 1995, American journal of hypertension,
D Sinagra, and D Greco, and A M Scarpitta, and V Bonaventura
March 2007, The journal of ECT,
Copied contents to your clipboard!